Renya Zhang

411 total citations
21 papers, 290 citations indexed

About

Renya Zhang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Renya Zhang has authored 21 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Renya Zhang's work include Renal cell carcinoma treatment (5 papers), Renal and related cancers (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Renya Zhang is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Renal and related cancers (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Renya Zhang collaborates with scholars based in China. Renya Zhang's co-authors include Wei Wang, Lei Li, Bo Xiang, Xiaoxiao Wu, Juan Yu, Jinguo Zhang, Jie Peng, Weilong Zhong, Yanrong Liu and Linlin Chen and has published in prestigious journals such as Oncogene, Medicine and Biomedicine & Pharmacotherapy.

In The Last Decade

Renya Zhang

21 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renya Zhang China 11 162 92 84 69 36 21 290
Sanket Shah India 11 186 1.1× 69 0.8× 89 1.1× 41 0.6× 66 1.8× 26 323
Chaping Cheng China 9 222 1.4× 112 1.2× 98 1.2× 91 1.3× 18 0.5× 11 365
Chiemi Saigo Japan 11 166 1.0× 94 1.0× 94 1.1× 84 1.2× 45 1.3× 50 362
Ali Hussain United States 5 129 0.8× 65 0.7× 55 0.7× 46 0.7× 29 0.8× 5 278
Yang Bao China 10 175 1.1× 86 0.9× 52 0.6× 81 1.2× 45 1.3× 22 308
Gaurav Kumar United States 9 153 0.9× 62 0.7× 104 1.2× 28 0.4× 41 1.1× 10 314
Carmen Z. Cantemir-Stone United States 6 259 1.6× 43 0.5× 167 2.0× 132 1.9× 42 1.2× 7 423
Mai Sugiyama Japan 13 210 1.3× 130 1.4× 45 0.5× 106 1.5× 36 1.0× 30 406
Rositsa Koleva United States 6 213 1.3× 66 0.7× 51 0.6× 46 0.7× 14 0.4× 7 314
Lanshan Huang China 12 198 1.2× 81 0.9× 53 0.6× 148 2.1× 22 0.6× 24 352

Countries citing papers authored by Renya Zhang

Since Specialization
Citations

This map shows the geographic impact of Renya Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renya Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renya Zhang more than expected).

Fields of papers citing papers by Renya Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renya Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renya Zhang. The network helps show where Renya Zhang may publish in the future.

Co-authorship network of co-authors of Renya Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Renya Zhang. A scholar is included among the top collaborators of Renya Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renya Zhang. Renya Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jianli, Xiao Zhi, Lili Yang, et al.. (2022). High expression of SDC1 in stromal cells is associated with good prognosis in colorectal cancer. Anti-Cancer Drugs. 34(4). 479–482. 4 indexed citations
2.
Li, Gang, et al.. (2021). Histopathological validation of safe margin for nephron-sparing surgery based on individual tumor growth pattern. World Journal of Surgical Oncology. 19(1). 255–255. 3 indexed citations
3.
Zhang, Renya, et al.. (2021). Sialadenoma papilliferum: clinicopathologic, Immunohistochemical, molecular analyses of new five cases and review of the literature. Diagnostic Pathology. 16(1). 22–22. 14 indexed citations
4.
Peng, Jie, Juan Yu, Jianli Liu, et al.. (2021). miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling. Cancer Cell International. 21(1). 702–702. 5 indexed citations
5.
Ma, Yong, et al.. (2021). Sporadic hemangioblastoma of the kidney: a clinicopathologic study of three cases and a literature review. Journal of International Medical Research. 49(7). 3619088702–3619088702. 2 indexed citations
6.
Li, Lu, Guoan Zhang, Qi Liu, et al.. (2020). Evaluation of allelic alterations in short tandem repeats in papillary thyroid cancer. Molecular Genetics & Genomic Medicine. 8(4). e1164–e1164. 6 indexed citations
7.
8.
Li, Xiaoxia, et al.. (2019). Primary cardiac malignant peripheral nerve sheath tumor: a case report. International journal of cardiac imaging. 35(9). 1615–1618. 4 indexed citations
9.
Li, Kaizhi, Lei Li, Xiaoxiao Wu, et al.. (2019). Loss of SDC1 Expression Is Associated with Poor Prognosis of Colorectal Cancer Patients in Northern China. Disease Markers. 2019. 1–7. 16 indexed citations
10.
Peng, Jie, Lei Li, Ying Xu, et al.. (2019). High expression of cytokeratin CAM5.2 in esophageal squamous cell carcinoma is associated with poor prognosis. Medicine. 98(37). e17104–e17104. 5 indexed citations
11.
Zong, Shumin, Weilong Zhong, Qian Zhang, et al.. (2019). Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins. Oncogene. 39(7). 1527–1542. 41 indexed citations
12.
Wang, Wei, et al.. (2019). Spindle cell lipoma: clinicopathologic characterization of 40 cases.. PubMed. 12(7). 2613–2621. 19 indexed citations
13.
Wang, Hongbo, et al.. (2019). Neuroendocrine neoplasms of the middle ear: report of 2 cases and review of the literature.. PubMed. 12(9). 3453–3458. 3 indexed citations
14.
Liu, Jianli, Sha Han, Jian Huang, et al.. (2018). CD51 is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Pathology - Research and Practice. 214(9). 1352–1355. 1 indexed citations
15.
Su, Ying, et al.. (2018). SETDB1 induces epithelial‑mesenchymal transition in breast carcinoma by directly binding with Snail promoter. Oncology Reports. 41(2). 1284–1292. 28 indexed citations
16.
Wang, Wei, Mei Yi, Renya Zhang, et al.. (2017). Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma. Molecular and Cellular Biochemistry. 438(1-2). 47–57. 35 indexed citations
17.
Huang, Jian, Lei Li, Jianli Liu, et al.. (2017). Altered expression of lysosomal associated membrane protein 1 in esophageal squamous cell carcinoma. Pathology - Research and Practice. 213(8). 938–942. 8 indexed citations
18.
Li, Gang, Yuhong Tang, Renya Zhang, et al.. (2015). Adult metanephric adenoma presumed to be all benign? A clinical perspective. BMC Cancer. 15(1). 310–310. 10 indexed citations
19.
Wei, Jianguo, Yan Li, Yuanyuan Wen, Lei Li, & Renya Zhang. (2015). Renal angiomyolipoma with epithelial cysts: a rare entity and review of literature.. PubMed. 8(9). 11760–5. 11 indexed citations
20.
Liu, Feifei, Renya Zhang, Zi-Yu Wang, et al.. (2014). Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.. PubMed. 7(9). 6409–14. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026